SEARCH

SEARCH BY CITATION

References

  • Arenzana-Seisdedos F., Thompson J., Rodriguez M. S., Bachelerie F., Thomas D., Hay R. T. (1995) Inducible nuclear expression of newly synthesized I kappa B alpha negatively regulates DNA-binding and transcriptional activities of NF-kappa B. Mol. Cell. Biol. 15, 26892696.
  • Bagasra O., Michaels F. H., Zheng Y. M., Bobroski L. E., Spitsin S. V., Fu Z. F., Tawadros R., Koprowski H. (1995) Activation of the inducible form of nitric oxide synthase in the brains of patients with multiple sclerosis. Proc. Natl Acad. Sci. USA 92, 1204112045.
  • Bo L., Dawson T. M., Wesselingh S., Mork S., Choi S., Kong P. A., Hanley D., Trapp B. D. (1994) Induction of nitric oxide synthase in demyelinating regions of multiple sclerosis brains. Ann. Neurol. 36, 778786.
  • Bondareff W., Mountjoy C. Q., Roth M. (1981) Selective loss of neurones of origin of adrenergic projection to cerebral cortex (nucleus locus coeruleus) in senile dementia. Lancet 1, 783784.
  • Burgher K. L., Heroux J. A., Ringheim G. E. (1997) Cyclic AMP potentiation of cytokine-induced nitric oxide synthase activity in a murine astrocyte cell line. Neurochem. Int. 30, 483489.DOI: 10.1016/s0197-0186(96)00085-x
  • Chelmicka-Schorr E., Kwasniewski M. N., Thomas B. E., Arnason B. G. (1989) The beta-adrenergic agonist isoproterenol suppresses experimental allergic encephalomyelitis in Lewis rats. J. Neuroimmunol. 25, 203207.
  • De Keyser J., Wilczak N., Leta R., Streetland C. (1999) Astrocytes in multiple sclerosis lack beta-2 adrenergic receptors. Neurology 53, 16281633.
  • Delgado M. & Ganea D. (2000) Inhibition of IFN-gamma-induced janus kinase-1-STAT1 activation in macrophages by vasoactive intestinal peptide and pituitary adenylate cyclase-activating polypeptide. J. Immunol. 165, 30513057.
  • Dinter H., Tse J., Halks-Miller M., Asarnow D., Onuffer J., Faulds D., Mitrovic B., Kirsch G., Laurent H., Esperling P., Seidelmann D., Ottow E., Schneider H., Tuohy V. K., Wachtel H., Perez H. D. (2000) The type IV phosphodiesterase specific inhibitor mesopram inhibits experimental autoimmune encephalomyelitis in rodents. J. Neuroimmunol. 108, 136146.DOI: 10.1016/s0165-5728(00)00265-4
  • Dlaska M. & Weiss G. (1999) Central role of transcription factor NF-IL6 for cytokine and iron-mediated regulation of murine inducible nitric oxide synthase expression. J. Immunol. 162, 61716177.
  • Eberhardt W., Pluss C., Hummel R., Pfeilschifter J. (1998) Molecular mechanisms of inducible nitric oxide synthase gene expression by IL-1beta and cAMP in rat mesangial cells. J. Immunol. 160, 49614969.
  • Endoh M., Maiese K., Wagner J. (1994) Expression of the inducible form of nitric oxide synthase by reactive astrocytes after transient global ischemia. Brain Res. 651, 92100.
  • Farmer P. & Pugin J. (2000) Beta-adrenergic agonists exert their anti-inflammatory effects in monocytic cells through the IkappaB/NF-kappaB pathway. Am. J. Physiol. Lung Cell. Mol. Physiol. 279, L675L682.
  • Feinstein D. L. (1998) Suppression of astroglial nitric oxide synthase expression by norepinephrine results from decreased NOS-2 promoter activity. J. Neurochem. 70, 14841496.
  • Feinstein D. L., Galea E., Reis D. J. (1993) Norepinephrine suppresses inducible nitric oxide synthase activity in rat astroglial cultures. J. Neurochem. 60, 19451948.
  • Feinstein D. L., Galea E., Roberts S., Berquist H., Wang H., Reis D. J. (1994) Induction of nitric oxide synthase in rat C6 glioma cells. J. Neurochem. 62, 315321.
  • Floyd R. A. (1999) Antioxidants, oxidative stress, and degenerative neurological disorders. Proc. Soc. Exp. Biol. Med. 222, 236245.
  • Galea E. & Feinstein D. L. (1999) Regulation of the expression of the inflammatory nitric oxide synthase (NOS2) by cyclic AMP. FASEB J. 13, 21252137.
  • Galea E., Feinstein D. L., Reis D. J. (1992) Induction of calcium-independent nitric oxide synthase activity in primary rat glial cultures. Proc. Natl Acad. Sci. USA 89, 1094510949.
  • Galea E., Reis D. J., Feinstein D. L. (1994) Cloning and expression of inducible nitric oxide synthase from rat astrocytes. J. Neurosci. Res. 37, 406414.
  • Genain C. P., Roberts T., Davis R. L., Nguyen M. H., Uccelli A., Faulds D., Li Y., Hedgpeth J., Hauser S. L. (1995) Prevention of autoimmune demyelination in non-human primates by a camp-specific phosphodiesterase inhibitor. Proc. Natl Acad. Sci. USA 92, 36013605.
  • Green L. C., Wagner D. A., Glogowski J., Skipper P. L., Wishnok J. S., Tannenbaum S. R. (1982) Analysis of nitrate, nitrite, and [15N]nitrate in biological fluids. Anal. Biochem. 126, 131138.
  • Gupta A. K. & Kone B. C. (1999) CCAAT/enhancer binding protein-beta trans-activates murine nitric oxide synthase 2 gene in an MTAL cell line. Am. J. Physiol. 276, F599F605.
  • Gupta A. K., Diaz R. A., Higham S., Kone B. C. (2000) Alpha-MSH inhibits induction of C/EBPbeta-DNA binding activity and NOS2 gene transcription in macrophages. Kidney Int. 57, 22392248.DOI: 10.1046/j.1523-1755.2000.00084.x
  • Hewett S. J., Corbett J. A., McDaniel M. L., Choi D. W. (1993) Interferon-gamma and interleukin-1 beta induce nitric oxide formation from primary mouse astrocytes. Neurosci. Lett. 164, 229232.
  • Hori K., Burd P. R., Furuke K., Kutza J., Weih K. A., Clouse K. A. (1999) Human immunodeficiency virus-1-infected macrophages induce inducible nitric oxide synthase and nitric oxide (NO) production in astrocytes: astrocytic NO as a possible mediator of neural damage in acquired immunodeficiency syndrome. Blood 93, 18431850.
  • Jovanova-Nesic K., Nikolic V., Jankovic B. D. (1993) Locus ceruleus and immunity. II. Suppression of experimental allergic encephalomyelitis and hypersensitivity skin reactions in rats with lesioned locus ceruleus. Int. J. Neurosci. 68, 289294.
  • Karaszewski J. W., Reder A. T., Anlar B., Arnason G. W. (1993) Increased high affinity beta-adrenergic receptor densities and cyclic AMP responses of CD8 cells in multiple sclerosis. J. Neuroimmunol. 43, 17.
  • Kinugawa K., Shimizu T., Yao A., Kohmoto O., Serizawa T., Takahashi T. (1997) Transcriptional regulation of inducible nitric oxide synthase in cultured neonatal rat cardiac myocytes. Circulation Res. 81, 911921.
  • Konkol R. J., Wesselmann U., Karpus W. J., Leo G. L., Killen J. A., Roerig D. L. (1990) Suppression of clinical weakness in experimental autoimmune encephalomyelitis associated with weight changes, and post-decapitation convulsions after intracisternal-ventricular administration of 6-hydroxydopamine. J. Neuroimmunol. 26, 2534.
  • Kunz D., Muhl H., Walker G., Pfeilschifter J. (1994) Two distinct signaling pathways trigger the expression of inducible nitric oxide synthase in rat renal mesangial cells. Proc. Natl Acad. Sci. USA 91, 53875391.
  • Lee S. C., Dickson D. W., Liu W., Brosnan C. F. (1993) Induction of nitric oxide synthase activity in human astrocytes by interleukin-1 beta and interferon-gamma. J. Neuroimmunol. 46, 1924.
  • Losier B. J. & Semba K. (1993) Dual projections of single cholinergic and aminergic brainstem neurons to the thalamus and basal forebrain in the rat. Brain Res. 604, 4152.
  • Lowenstein C. J., Alley E. W., Raval P., Snowman A. M., Snyder S. H., Russell S. W., Murphy W. J. (1993) Macrophage nitric oxide synthase gene: two upstream regions mediate induction by interferon gamma and lipopolysaccharide. Proc. Natl Acad. Sci. USA 90, 97309734.
  • Loy R., Koziell D. A., Lindsey J. D., Moore R. Y. (1980) Noradrenergic innervation of the adult rat hippocampal formation. J. Comp. Neurol. 189, 699710.
  • MacMicking J., Xie Q. W., Nathan C. (1997) Nitric oxide and macrophage function. Ann. Rev. Immunol. 15, 323350.
  • Mann D. M., Lincoln J., Yates P. O., Stamp J. E., Toper S. (1980) Changes in the monoamine containing neurones of the human CNS in senile dementia. Br. J. Psych. 136, 533541.
  • Manna S. K. & Aggarwal B. B. (1998) Alpha-melanocyte-stimulating hormone inhibits the nuclear transcription factor NF-kappa B activation induced by various inflammatory agents. J. Immunol. 161, 28732880.
  • Milner T. A., Shah P., Pierce J. P. (2000) beta-adrenergic receptors primarily are located on the dendrites of granule cells and interneurons but also are found on astrocytes and a few presynaptic profiles in the rat dentate gyrus. Synapse 36, 178193.DOI: 10.1002/(sici)1098-2396(20000601)36:3<178::aid-syn3>3.3.co;2-y
  • Muhl H., Kunz D., Pfeilschifter J. (1994) Expression of nitric oxide synthase in rat glomerular mesangial cells mediated by cyclic AMP. Br. J. Pharmacol. 112, 18.
  • Oda H., Murayama T., Nomura Y. (1997) Inhibition of inducible nitric oxide synthase expression by endothelin in rat glial cells prepared from the neonatal rat brain. J. Neurochem. 69, 669674.
  • Pahan K., Namboodiri A. M., Sheikh F. G., Smith B. T., Singh I. (1997) Increasing cAMP attenuates induction of inducible nitric-oxide synthase in rat primary astrocytes. J. Biol. Chem. 272, 77867791.DOI: 10.1074/jbc.272.12.7786
  • Parry G. C. & Mackman N. (1997) Role of cyclic AMP response element-binding protein in cyclic AMP inhibition of NF-kappaB-mediated transcription. J. Immunol. 159, 54505456.
  • Pati D., Meistrich M. L., Plon S. E. (1999) Human Cdc34 and Rad6B ubiquitin-conjugating enzymes target repressors of cyclic AMP-induced transcription for proteolysis. Mol. Cell. Biol. 19, 50015013.
  • Perrella M. A., Patterson C., Tan L., Yet S. F., Hsieh C. M., Yoshizumi M., Lee M. E. (1996) Suppression of interleukin-1beta-induced nitric-oxide synthase promoter/enhancer activity by transforming growth factor-beta1 in vascular smooth muscle cells. Evidence for mechanisms other than NF-kappaB. J. Biol. Chem. 271, 1377613780.DOI: 10.1074/jbc.271.23.13776
  • Schreiber E., Himmelmann A., Malipiero U., Tobler A., Stahel R., Fontana A. (1992) Human small cell lung cancer expresses the octamer DNA-binding and nervous system-specific transcription factor N-Oct 3 (Brain-2). Cancer Res. 52, 61216124.
  • Simmons M. L. & Murphy S. (1992) Induction of nitric oxide synthase in glial cells. J. Neurochem. 59, 897905.
  • Simmons M. L. & Murphy S. (1993) Cytokines regulate l-arginine-dependent cyclic gmp production in rat glial cells. Eur. J. Neurosci. 5, 825831.
  • Sommer N., Loschmann P. A., Northoff G. H., Weller M., Steinbrecher A., Steinbach J. P., Lichtenfels R., Meyermann R., Riethmuller A., Fontana A. (1995) The antidepressant rolipram suppresses cytokine production and prevents autoimmune encephalomyelitis [see comments]. Nat. Med. 1, 244248.
  • Spink J., Cohen J., Evans T. J. (1995) The cytokine responsive vascular smooth muscle cell enhancer of inducible nitric oxide synthase. Activation by nuclear factor- kappa B. J. Biol. Chem. 270, 2954129547.DOI: 10.1074/jbc.270.49.29541
  • Stasiolek M., Gavrilyuk V., Sharp A., Horvath P., Selmaj K., Feinstein D. L. (2000) Inhibitory and stimulatory effects of lactacystin on expression of nitric oxide synthase type 2 in brain glial cells. The role of Ikappa B-beta. J. Biol. Chem. 275, 2484724856.DOI: 10.1074/jbc.m910284199
  • Vodovotz Y., Lucia M. S., Flanders K. C., Chesler L., Xie Q. W., Smith T. W., Weidner J., Mumford R., Webber R., Nathan C., Roberts A. B., Lippa C. F., Sporn M. B. (1996) Inducible nitric oxide synthase in tangle-bearing neurons of patients with Alzheimer's disease. J. Exp. Med. 184, 14251433.
  • Wadleigh D. J., Reddy S. T., Kopp E., Ghosh S., Herschman H. R. (2000) Transcriptional activation of the cyclooxygenase-2 gene in endotoxin-treated RAW 264.7 macrophages. J. Biol. Chem. 275, 62596266.DOI: 10.1074/jbc.275.9.6259
  • Wallace M. N., Geddes J. G., Farquhar D. A., Masson M. R. (1997) Nitric oxide synthase in reactive astrocytes adjacent to beta- amyloid plaques. Exp. Neurol. 144, 266272.DOI: 10.1006/exnr.1996.6373
  • Westlund K. N., Bowker R. M., Ziegler M. G., Coulter J. D. (1983) Noradrenergic projections to the spinal cord of the rat. Brain Res. 263, 1531.
  • White S. R., Bhatnagar R. K., Bardo M. T. (1983) Norepinephrine depletion in the spinal cord gray matter of rats with experimental allergic encephalomyelitis. J. Neurochem. 40, 17711773.
  • Wiegmann K., Muthyala S., Kim D. H., Arnason B. G., Chelmicka-Schorr E. (1995) Beta-adrenergic agonists suppress chronic/relapsing experimental allergic encephalomyelitis (CREAE) in Lewis rats. J. Neuroimmunol. 56, 201206.DOI: 10.1016/0165-5728(94)00153-f
  • Xie Q. W., Whisnant R., Nathan C. (1993) Promoter of the mouse gene encoding calcium-independent nitric oxide synthase confers inducibility by interferon gamma and bacterial lipopolysaccharide. J. Exp. Med. 177, 17791784.
  • Xie Q. W., Kashiwabara Y., Nathan C. (1994) Role of transcription factor nf-kappa b/rel in induction of nitric oxide synthase. J. Biol. Chem. 269, 47054708.
  • Zeinstra E., Wilczak N., De Keyser J. (2000) [3H]Dihydroalprenolol binding to beta adrenergic receptors in multiple sclerosis brain. Neurosci. Lett. 289, 7577.DOI: 10.1016/s0304-3940(00)01254-4
  • Zhang X., Laubach V. E., Alley E. W., Edwards K. A., Sherman P. A., Russell S. W., Murphy W. J. (1996) Transcriptional basis for hyporesponsiveness of the human inducible nitric oxide synthase gene to lipopolysaccharide/interferon-gamma. J. Leukoc. Biol. 59, 575585.
  • Zhang H. F., Chen X. S., Teng X. W., Snead C., Catravas J. D. (1998) Molecular cloning and analysis of the rat inducible nitric oxide synthase gene promoter in aortic smooth muscle cells. Biochem. Pharmacol. 55, 18731880.DOI: 10.1016/s0006-2952(98)00078-1
  • Zhong H., SuYang H., Erdjument-Bromage H., Tempst P., Ghosh S. (1997) The transcriptional activity of NF-kappaB is regulated by the IkappaB-associated PKAc subunit through a cyclic AMP-independent mechanism. Cell 89, 413424.
  • Zimmermann J., Erdmann D., Lalande I., Grossenbacher R., Noorani M., Furst P. (2000) Proteasome inhibitor induced gene expression profiles reveal overexpression of transcriptional regulators ATF3, GADD153 and MAD1. Oncogene 19, 29132920.